177A — Kohjin Bio Co Cashflow Statement
0.000.00%
Last trade - 00:00- ¥9bn
- ¥8bn
- ¥5bn
- 75
- 51
- 28
- 52
Annual cashflow statement for Kohjin Bio Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | Yuho | Tanshin |
| Standards: | JAS | JAS | JAS | — |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | 922 | 1,244 | 636 | 1,015 |
| Depreciation | ||||
| Non-Cash Items | 69.1 | 39.2 | -42.4 | -80.5 |
| Unusual Items | ||||
| Equity in Net Earnings/Losses | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | -407 | -990 | -69.2 | -380 |
| Change in Accounts Receivable | ||||
| Change in Inventories | ||||
| Change in Accounts Payable | ||||
| Change in Payable / Accrued Expenses | ||||
| Change in Taxes Payable | ||||
| Change in Other Liabilities | ||||
| Other Operating Cash Flow | ||||
| Cash from Operating Activities | 763 | 461 | 824 | 916 |
| Capital Expenditures | -204 | -561 | -563 | -887 |
| Purchase of Fixed Assets | ||||
| Purchase / Acquisition of Intangibles | ||||
| Other Investing Cash Flow Items | 286 | -14.7 | -14.6 | -203 |
| Sale of Fixed Assets | ||||
| Purchase of Investments | ||||
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | 82.8 | -575 | -577 | -1,091 |
| Financing Cash Flow Items | -33.9 | -41.6 | -79.1 | -15.6 |
| Other Financing Cash Flow | ||||
| Total Cash Dividends Paid | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | -360 | -172 | -1.35 | 1,376 |
| Foreign Exchange Effects | ||||
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 515 | -272 | 264 | 1,222 |